Invesco Ltd. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$60,000
-42.3%
92,057
-3.1%
0.00%
Q4 2021$104,000
-44.7%
94,989
-7.4%
0.00%
Q3 2021$188,000
-17.2%
102,635
+19.1%
0.00%
Q2 2021$227,000
+22.0%
86,169
+67.1%
0.00%
Q1 2021$186,000
+77.1%
51,570
+23.4%
0.00%
Q4 2020$105,000
+250.0%
41,776
+253.6%
0.00%
Q3 2020$30,000
-18.9%
11,815
+5.3%
0.00%
Q2 2020$37,000
+37.0%
11,220
+0.9%
0.00%
Q1 2020$27,000
-90.4%
11,124
-81.3%
0.00%
Q4 2019$281,000
-89.2%
59,463
-86.7%
0.00%
-100.0%
Q2 2019$2,602,000
-60.9%
446,376
-57.5%
0.00%
-50.0%
Q1 2017$6,657,000
+18.6%
1,050,018
+0.1%
0.00%0.0%
Q4 2016$5,611,000
+6424.4%
1,048,864
+6800.4%
0.00%
Q3 2016$86,000
-98.4%
15,200
-98.4%
0.00%
-100.0%
Q2 2016$5,311,000
-18.1%
967,332
+10.7%
0.00%
-33.3%
Q1 2016$6,483,000
+130.9%
873,684
+273.4%
0.00%
+200.0%
Q2 2015$2,808,000
-22.3%
234,011
-30.3%
0.00%0.0%
Q1 2015$3,615,000
+9.3%
335,624
-53.5%
0.00%0.0%
Q1 2014$3,308,000722,3420.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders